Chief Scientific Officer (CSO)
Engineering the future of antibody drug development to change the course of people’s lives! Join an ambitious techbio start-up transforming drug discovery using AI!
We usually respond within a day
Chief Scientific Officer
Antiverse
Engineering the future of antibody drug development to change the course of people’s lives!
Do you want to be part of an ambitious techbio start-up successfully tackling an issue nobody thought possible?
Antiverse is seeking a visionary Chief Scientific Officer to build a differentiated biologics pipeline by leveraging our AI-driven platform for epitope-specific antibody design. The ideal candidate is a biotech leader, well-regarded by investors and pharma, with the agility to thrive in a fast-paced startup environment. They will have a key role in the new phase of Antiverse by developing our biologics pipeline from discovery through IND and beyond, working closely with the C-suite and the board.
Join us to grow and evolve with a company transforming drug discovery!
Culture and Values
We believe in the power of autonomy nurtured in a culture with the following values.
People first
We work to make things better for everyone: both on a societal level and a personal level. We will thrive, as a team, as a company and as a society by combining smartness with thoughtfulness across everything we do.
Rigour & agility
We move fast and innovate in our thinking, yet combine this agility with utter rigour and robustness. We are dedicated to delivering rock-solid solutions.
Interdisciplinarity
An ugly word for a beautiful idea. Our interdisciplinary approach goes deeper than our science. We believe that the best ideas and the most interesting conversations often come from synthesising diverse expertise and experiences.
Dignity & nurture
We fundamentally believe in the value of each individual and the worth of their contribution regardless of the outcome. We believe that we all thrive best in a nurturing environment, and everything in our power is committed to building this supportive culture.
Go where there's a need
We have the potential to transform lives. We will not let ourselves be sidetracked in this calling. We will not fail those whose future we can save.
How can you contribute
As the CSO, you will build and execute the strategy to develop a different biologics pipeline and be the architect for this new phase of Antiverse. You will be responsible for target selection, antibody design, and development all the way to the IND. The ideal candidate is a strategic thinker who can marry AI with wet-lab technologies to innovate in target discovery, validation, biologic design and efficacy and tox prediction.
Day-to-day activities
Each day can look very different at Antiverse, with new priorities coming in quickly. Below is a rough outline of the work you'll be involved in
- Develop and execute a pipeline strategy from target selection (GPCRs and ion channels) to IND
- Transition AI-designed hits (anything with a H-chain) into preclinical and IND-ready biologics.
- Leverage AI to rethink target validation, antibody optimisation, developability and efficacy/tox prediction
- Establish credibility with investors and pharma partners.
- Manage collaborations and external partnerships.
- Provide strategic leadership and scientific direction to internal teams.
Who you are
- You are an expert in GPCRs and/or ion channels/solute careers
- Expertise in working with preclinical model providers and CDMOs.
- You are a results-driven professional with a passion for changing the life of patients
- You thrive in fast-paced environments and can identify opportunities to streamline processes.
- As a natural leader, you excel at managing teams and motivating them to achieve their best.
- Your strategic mindset allows you to anticipate challenges and develop innovative solutions.
- With strong analytical skills, you’re comfortable using data to inform decisions and drive continuous improvement. You are detail-oriented yet able to see the big picture, ensuring that day-to-day operations align with the company's long-term goals.
- PhD in Biology, Biochemistry, or Molecular Biology.
- 15+ years of experience in areas from target selection to antibody development
- Strong track record in pharma and investor relations.
If you look at this list and think you could do this and are excited by the opportunity but not a perfect match, please get in touch anyway! We believe it's much easier to develop technical expertise than develop motivation & excitement, and we're willing to invest our time and expertise in the right individual with the right motivations.
Benefits
- Become part of a top team at the intersection of Machine Learning and Drug discovery.
- Commitment to invest in your development, both technical and professional.
- Stock Options
- 25 days + public holidays
- Summer Fridays (extra 3 days off during July - August)
- Flexible working hours
- Hybrid work (Offices in Cambridge, USA and HQ in Cardiff, UK)
- Allowances for equipment both for home and office
- Discounted Gym and Pool membership
- Health Insurance
- Referral Bonus
Keywords; GPCR, Ion Channel, CSO, Chief Scientific Officer, Pipeline, GMP, CMC, IND, Biologics, Target Selection, Antibody Develoment, AI, Machine Learning
No recruiters, please.
- Department
- Discovery Team
- Locations
- HQ - Cardiff
- Remote status
- Hybrid
About Antiverse
Antiverse was founded by Ben Holland, Murat Tunaboylu and Rowina Westermeir at the Deep Science Ventures Accelerator Programme in 2017. Their objective was to create new enabling technologies in antibody discovery using artificial intelligence that allows for the creation of new therapies against the industry's most challenging targets. Since then, Antiverse has worked with five companies in antibody discovery programmes aimed at several GPCRs, Ion Channels and other challenging targets. In addition, we are developing our own internal pipeline, and have raised around $10.1 million.
Chief Scientific Officer (CSO)
Engineering the future of antibody drug development to change the course of people’s lives! Join an ambitious techbio start-up transforming drug discovery using AI!
Loading application form